Monday, November 26, 2012 Friday, November 23, 2012 Wednesday, November 21, 2012- Biotech Banter: Is This Pharma Giant a Keeper?at Motley Fool (Wed, Nov 21)
- Pfizer: Win Some, Lose Someat Motley Fool (Wed, Nov 21)
- Billionaire Israel Englander’s Latest Picks May Surprise Youat Motley Fool (Wed, Nov 21)
- Are Short-Sellers Onto Something at Spectrum Pharmaceuticals?at Motley Fool (Wed, Nov 21)
- Is This Biotech Fishing for a Higher Bid?at Motley Fool (Wed, Nov 21)
- Teva Focused on Smaller M&A, Frost Says: Israel Overnightat Bloomberg (Wed, Nov 21)
- Revisiting Buyout Rumors After Teva's CEO Shifts Focus To 'Smaller Acquisitions'at Seeking Alpha (Wed, Nov 21)
- 3 Things to Watch With Antares Pharmaat Motley Fool (Wed, Nov 21)
Tuesday, November 20, 2012 Friday, November 16, 2012- No News Equals Bad News for Amarin Investorsat Motley Fool (Fri, Nov 16)
- Amarin Pushed Closer to Solo Vascepa Launch By Another NCE Delayat TheStreet (Fri, Nov 16)
- Investors Still Waiting for Decision on Amarin Fish-Oil Drug Exclusivityat Minyanville (Fri, Nov 16)
- [video] Gaza, Rockets & Israel Stocksat CNBC (Fri, Nov 16)
- 3 Undervalued Generic Producers To Buyat Motley Fool (Fri, Nov 16)
- Too Much Selling of Top Quartile Ranked Dividend Stock TEVAat Forbes (Fri, Nov 16)
- 5 Stocks Pushing The Drugs Industry Lowerat TheStreet (Fri, Nov 16)
- Is Threshold on the Threshold?at Motley Fool (Fri, Nov 16)
- Israeli Stocks Hit by Conflict Turbulenceat CNBC (Fri, Nov 16)
- ArcelorMittal Divests Stake, Multiple Bidders Possible for Amarin: Merger and Acquisitions Updateat Wall St. Cheat Sheet (Fri, Nov 16)
Thursday, November 15, 2012Add TEVA News to My Yahoo!   | |
|
0.80%